Free Trial

Clene (CLNNW) Competitors

$0.03 0.00 (0.00%)
As of 07:00 AM Eastern

CLNNW vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ACABW, BFRIW, BTMDW, BCTXW, and CELUW

Should you be buying Clene stock or one of its competitors? The main competitors of Clene include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), BriaCell Therapeutics (BCTXW), and Celularity (CELUW). These companies are all part of the "pharmaceutical products" industry.

Clene vs.

Clene (NASDAQ:CLNNW) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, media sentiment, profitability, risk, community ranking, earnings, analyst recommendations, dividends and valuation.

In the previous week, Clene's average media sentiment score of 0.00 equaled 180 Life Sciences'average media sentiment score.

Company Overall Sentiment
Clene Neutral
180 Life Sciences Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Clene$350KN/AN/AN/AN/A
180 Life SciencesN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
CleneN/A N/A N/A
180 Life Sciences N/A N/A N/A

Clene and 180 Life Sciences both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
CleneN/AN/A
180 Life SciencesN/AN/A

Summary

Clene beats 180 Life Sciences on 1 of the 1 factors compared between the two stocks.

Get Clene News Delivered to You Automatically

Sign up to receive the latest news and ratings for CLNNW and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CLNNW vs. The Competition

MetricCleneBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$129.09M$5.34B$8.44B
Dividend YieldN/A3.74%5.21%4.11%
P/E RatioN/A3.4126.9019.78
Price / SalesN/A4,131.64389.48118.91
Price / CashN/A13.1938.2534.62
Price / BookN/A33.186.784.52
Net IncomeN/A-$91.56M$3.23B$248.23M
7 Day PerformanceN/A3.16%2.02%0.81%
1 Month PerformanceN/A8.05%10.97%13.32%
1 Year PerformanceN/A99.15%17.38%7.69%

Clene Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CLNNW
Clene
N/A$0.03
flat
N/A-6.3%$0.00$350,000.000.00100
ATNFW
180 Life Sciences
N/A$0.01
+18.8%
N/A+15.6%$0.00N/A0.007Positive News
Gap Down
LBPSW
4D pharma
N/AN/AN/AN/A$0.00$522,000.000.00N/A
AEHAW
Aesther Healthcare Acquisition
N/A$0.00
-84.6%
N/A-82.3%$0.00N/A0.002
AIMDW
Ainos
N/A$0.17
+10.7%
N/AN/A$0.00$20,729.000.0040
ALVOW
Alvotech
N/A$1.86
-5.1%
N/A-41.9%$0.00$585.60M0.004Positive News
Gap Up
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.02
flat
N/AN/A$0.00N/A0.0015
BFRIW
Biofrontera
N/A$0.18
+25.0%
N/A+174.4%$0.00$37.32M0.0070Gap Up
BTMDW
biote
N/A$0.02
-5.9%
N/A-94.0%$0.00$199.38M0.00N/AGap Up
High Trading Volume
BCTXW
BriaCell Therapeutics
N/A$0.08
+12.6%
N/A-82.5%$0.00N/A0.008
CELUW
Celularity
N/A$0.05
+33.3%
N/A+72.5%$0.00$54.22M0.00220Gap Down

Related Companies and Tools


This page (NASDAQ:CLNNW) was last updated on 5/22/2025 by MarketBeat.com Staff
From Our Partners